GENB
Generate Biomedicines, Inc.
14.00$
+3.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -603.0% | -481.3% | -1,112.8% | -917.7% | |
| 38.7% | 32.8% | 45.3% | 51.1% | |
| 53.8% | 54.2% | 88.5% | 130.5% | |
| -197.8% | -13.5% | -424.3% | -70.6% | |
| 8.5% | 1.5% | 52.3% | 14.8% | |
| – | – | -3,494.4% | 527.6% | |
| -30.0% | -23.8% | -15.4% | -15.7% | |
| 233.2% | -2.6% | 5,141.1% | -9.2% | |
| 486.7% | -652.4% | 2,222.8% | -399.3% | |
| -611.6% | -482.8% | -1,165.1% | -932.5% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.